Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Portfolio Review of Hereditary Blood Disorders, 6501 [E6-1677]

Download as PDF 6501 Federal Register / Vol. 71, No. 26 / Wednesday, February 8, 2006 / Notices ESTIMATE OF ANNUALIZED BURDEN TABLE Number of respondents Type of data collection PACE EH Requestor Survey ....................................................................................................... PACE EH Participant Interviews ................................................................................................. Dated: February 1, 2006. Betsey Dunaway, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6–1695 Filed 2–7–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES and the Agency for Toxic Substances and Disease Registry. Dated: February 2, 2006. Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–1689 Filed 2–7–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Committee to the Director, Centers for Disease Control and Prevention; Meeting rmajette on PROD1PC67 with NOTICES1 Centers for Disease Control and Prevention Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following Advisory Committee meeting. Name: Advisory Committee to the Director (ACD), CDC. Time and Date: 8:30 a.m.–4:30 p.m., February 23, 2006. Place: CDC, Global Communications Center (Building 19), 1600 Clifton Road, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: The committee will provide advice to the CDC Director on strategic and other broad issues facing CDC. Matters To Be Discussed: Agenda items will include updates on CDC priorities with discussions of program activities including updates on CDC scientific and programmatic activities, strategic imperatives, goals, research agenda, and health equity. Agenda items are subject to change as priorities dictate. For Further Information Contact: Lynn Austin, PhD., Executive Secretary, Advisory Committee to the Director, CDC, 1600 Clifton Road, NE., M/S D–14, Atlanta, Georgia 30333. Telephone 404/ 639–7000. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Portfolio Review of Hereditary Blood Disorders VerDate Aug<31>2005 19:41 Feb 07, 2006 Jkt 208001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Portfolio Review of Hereditary Blood Disorders. Times and Dates: 9:30 a.m.–5 p.m., March 2, 2006 (Closed). 9 a.m.–4 p.m., March 3, 2006 (Closed). Place: National Center on Birth Defects and Developmental Disabilities, CDC, 12 Executive Park Drive, Atlanta, GA 30329, Telephone Number 404.498.3800. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the review and discussion of the Hereditary Blood Disorders Division’s strategies and activities. For Further Information Contact: Esther Sumartojo, Acting Associate Director for Science and Public Health, National Center on Birth Defects and Developmental Disabilities, CDC, 1600 Clifton Road, NE., Mailstop E–87, Atlanta, GA 30333, Telephone Number 404.498.3800. PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 Number of responses per respondent Average burden per response (in hours) 1 1 45/60 1 872 192 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 2, 2006. Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–1677 Filed 2–7–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Environmental Health/Agency for Toxic Substances and Disease Registry The Community and Tribal Subcommittee (CTS) of the Board of Scientific Counselors (BSC), Centers for Disease Control and Prevention (CDC), National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (NCEH/ATSDR): Teleconference. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC, NCEH/ATSDR announces the following subcommittee meeting: Name: Community and Tribal Subcommittee (CTS). Time and Date: 1 p.m.–2:30 p.m., February 27, 2006. Place: The teleconference will originate at NCEH/ATSDR in Atlanta, Georgia. Please see Supplementary Information for details on accessing the teleconference. Status: Open to the public, teleconference access limited only by availability of telephone ports. Purpose: Under the charge of the BSC, NCEH/ATSDR the CTS will provide the board with a forum for community and tribal first-hand perspectives on the interactions and impacts of the NCEH/ E:\FR\FM\08FEN1.SGM 08FEN1

Agencies

[Federal Register Volume 71, Number 26 (Wednesday, February 8, 2006)]
[Notices]
[Page 6501]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-1677]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Portfolio Review of Hereditary Blood Disorders

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:
    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Portfolio Review of Hereditary Blood 
Disorders.
    Times and Dates: 9:30 a.m.-5 p.m., March 2, 2006 (Closed). 9 a.m.-4 
p.m., March 3, 2006 (Closed).
    Place: National Center on Birth Defects and Developmental 
Disabilities, CDC, 12 Executive Park Drive, Atlanta, GA 30329, 
Telephone Number 404.498.3800.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review and 
discussion of the Hereditary Blood Disorders Division's strategies and 
activities.
    For Further Information Contact: Esther Sumartojo, Acting Associate 
Director for Science and Public Health, National Center on Birth 
Defects and Developmental Disabilities, CDC, 1600 Clifton Road, NE., 
Mailstop E-87, Atlanta, GA 30333, Telephone Number 404.498.3800.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: February 2, 2006.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E6-1677 Filed 2-7-06; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.